Navigation Links
Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
Date:8/28/2012

BATON ROUGE, La., Aug. 28, 2012 /PRNewswire/ -- Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that over‐express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over‐expressed in a wide range of cancers including ovarian cancer. In June, the Company presented results from the successful completion of a Phase 1 study of EP‑100 in advanced solid tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting.

"We are pleased with the continued momentum behind EP‑100 and the progress of enrollment as we begin the randomized treatment phase," said Dr. Hector Alila, CEO of Esperance. "We are encouraged with early results, and look forward to accelerating enrollment in a very important, underserved patient population and providing an update on the clinical progress over time."

The randomized, Phase 2 trial of EP‑100 in combination with paclitaxel versus paclitaxel alone in patients with histologically confirmed epithelial ovarian carcinomas expressing LHRH‐receptors is actively enrolling patients in key clinical sites across the United States. Rationale for the study is based on the positive clinical evidence from escalating doses in 38 patients in the Phase 1 study and on preclinical studies showing synergies between EP‑100 and various chemotherapeutic agents.

About EP‑100

EP‑100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP™) platform technology, is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their s
'/>"/>

SOURCE Esperance Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
2. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
3. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
4. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
5. Actinium Pharmaceuticals Strengthens Management Team
6. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
7. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
8. Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
9. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
10. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
11. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Mass. , June 18, 2013 Decision Resources, ... pharmaceutical and healthcare issues, finds that, over the past 12 ... France , Germany , ... the United Kingdom ) have been required ... of their HIV patients, primarily to reduce costs. Additionally, more ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... 18, 2013 Remedy Informatics, a leading ... life sciences research, today announced it has been ... Schedule 70 supply contract (GS-35F-367AA, effective May 7, ... IT solutions to government agencies at federal, state ... Remedy has placed its products and services on ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
... ROTTERDAM, The Netherlands , July 8, 2010 , ... - Novel Platform Set to Transform Human Therapeutic ... arGEN-X, ... proprietary SIMPLE,Antibody(TM) platform, announces that it has been granted the first patent,covering the platform. ...
Cached Medicine Technology:Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 2arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 4
(Date:6/19/2013)... 19, 2013 According to Vanessa Grigoriadis, ... called “psychonauts” are creating new designer drugs featuring psychoactive ... of published documents and patented formulas. She reported her ... Now on June 4. , “Some of these ... never tested on humans. Maybe some of them are ...
(Date:6/19/2013)... The Report "Data Center Security Market [Logical ... UTM, IAM, SIEM, DR, ILM); Physical Security (PSIM, ... Forecasts & Analysis (2013-2018)", defines and segments the ... with in-depth analysis and forecasting of revenues. It ... with insights into trends, opportunities, and challenges. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Tools4ever, a ... sponsoring today's event, at which it will be giving ... well as giving further insight into its leading-edge solutions. ... IT & business professionals specialising in IDM infrastructure and ... of markets including the public sector, banking, finance and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Recovery Associates, ... upon crystal meth addiction treatment, helping men and women ... drug. , Crystal meth is a stimulant named for ... drug is most commonly smoked, but it can also ... commonly created in homemade labs using common household ingredients ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US ... test that has been specifically designed to help a recipient ... if their blood contains elevated levels of cobalt, and chromium, ... to see how the device is doing. In the event ... explain the possible options the person will need to consider, ...
Breaking Medicine News(10 mins):Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4Health News:Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates 2Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2
... want doctors to be ready to handle medical problems and ... //In the present state, what happens when a person develops ... back to normal conditions for treatment in time simply because ... from a UF study show there is little difference in ...
... has not yet been discovered. Currently,its diagnosis means, high-dose ... the cancer – a watch and wait approach. Recently, ... Belgium explored the possibility of providing patients with continuous ... be published in the November 15, 2006, issue of ...
... to open in Bihar as two US and six Indian ... ,"The Bihar State Investment Promotion Board (SIPB) has ... private sector," said a state official on condition of anonymity. ... in the health sector," he added. ,According to ...
... policymakers to ensure equal access to treatment and livelihood ... social vulnerability., ,"It is imperative to see that ... get equal opportunities to access treatment," stated the National ... on 'Gender impact of HIV and AIDS in India', ...
... million pounds have been pledged to mental hospitals around ... for inmates. A report published early this year by// ... incidents of attempted rape and specifically mentioned 19 incidents ... has catapulted this decision from the government. ...
... Infant Death Syndrome (SIDS) or 'cot death' that kills about ... a defect in the brain, scientists have said.// ... in the US compared the brains of cot death victims ... conditions. , ,They discovered a defect in the brain ...
Cached Medicine News:Health News:Researchers explore medicine in space 2Health News:Researchers explore medicine in space 3Health News:Fighting cancer - Multiple Myeloma with long-term therapy 2Health News:Equal Opportunities For HIV-Positive Women Urged 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: